Withdrawn trial: thyroid hormone spray for COVID lungs never tested
NCT ID NCT04725110
First seen Feb 13, 2026 · Last updated Jun 16, 2026 · Updated 24 times
Summary
This study planned to test a thyroid hormone (T3) given directly into the lungs of COVID-19 patients with severe breathing failure (ARDS) who were on ventilators. The goal was to reduce lung fluid and improve recovery. However, the trial was withdrawn before any patients were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55117, United States
Conditions
Explore the condition pages connected to this study.